Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

RNAC holding history

Cartesian Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RNAC overviewAll 13F holders of RNACFull Q2 2026 holdings

Shares (Q2 2026)
208,647
Value
$2.17M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of RNAC by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026208,647$2.17M<0.1%+71,807+52.5%AddedHolders
Q1 2026136,840$841.6K<0.1%+69,499+103.2%AddedHolders
Q4 202567,341$485.5K<0.1%+57,393+576.9%AddedHolders
Q3 20259,948$101.7K<0.1%−3,258−24.7%ReducedHolders
Q2 202513,206$137.2K<0.1%−17,912−57.6%ReducedHolders
Q1 202531,118$410.1K<0.1%+13,538+77.0%AddedHolders
Q4 202417,580$314.9K<0.1%+12,241+229.3%AddedHolders
Q3 20245,339$86.1K<0.1%+3,102+138.7%AddedHolders
Q2 20242,237$60.4K<0.1%−115,189−98.1%ReducedHolders
Q1 2024117,426$76.3K<0.1%−14,338−10.9%ReducedHolders
Q4 2023131,764$90.8K<0.1%+71,464+118.5%AddedHolders
Q3 202360,300$63.9K<0.1%−3,313−5.2%ReducedHolders
Q2 202363,613$71.2K<0.1%+63,613NewHolders
Q4 20220$00.0%−11,102−100.0%Sold outHolders
Q3 202211,102$18.0K<0.1%+11,102NewHolders
Q2 20220$00.0%−1,171−100.0%Sold outHolders
Q1 20221,171$1.00K<0.1%−24,121−95.4%ReducedHolders
Q4 202125,292$82.0K<0.1%−124,343−83.1%ReducedHolders
Q3 2021149,635$622.0K<0.1%+143,910+2,513.7%AddedHolders
Q2 20215,725$24.0K<0.1%−292,074−98.1%ReducedHolders
Q1 2021297,799$1.35M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.